PubMed Health⌕ Search

PubMed · 3545311

Hepatitis delta virus infection.

Abstract

The hepatitis delta virus (HDV) is a defective virus dependent for replication and infection on helper functions provided by the hepatitis B virus (HBV). HDV and HBV co-infection occurs mainly in acute hepatitis patients with frequent parenteral exposure such as intravenous drug addicts and transfused patients. In contrast, co-infection is very rare in patients with other sources of infection and usually is a self limited disease. HDV superinfection of HBsAg carriers may have a severe course and proceed to chronic active liver disease. Active immunoprophylaxis against HBV should be considered as the only preventive measure against HDV infection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G Papaevangelou, N Tassopoulos. 1986. Hepatitis delta virus infection.. https://pubmed.ncbi.nlm.nih.gov/3545311/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Natural course and treatment of hepatitis D virus infection.

Hepatitis D virus (HDV) is a subviral satellite with hepatitis B virus (HBV) as its natural helper virus. After entry into hepatocytes, it utilizes host cellular enzymes to replicate by a double-rolling-circle mechanism. HDV is most often transmitted by contact with contaminated blood and body fluid, similar to HBV infection. Approximately 5% of the global HBV carriers are coinfected with HDV, leading to a total of 10-15 million HDV carriers worldwide. HDV infection can occur concurrently with HBV infection (coinfection) or in a patient with established HBV infection (superinfection). The pathogenesis of HDV remains controversial. A decline in the prevalence of both acute and chronic hepatitis D (CHD) has been observed worldwide. At present, therapy for chronic HDV infection is by the use of interferon-alpha. Compared to chronic hepatitis B or C, CHD treatment requires a higher dosage and a longer duration of treatment, and post-treatment relapses are common. In order to prevent the progression of CHD and its related morbidity and mortality, more effective treatments are needed.

Hepatitis D↗